Acura Pharmaceuticals

(OTC) ACUR

Current Price$0.00

Market Cap$6.60K

Since IPO (1986)-100%

5 Year-100%

1 Year-50%

1 Month-50%

Acura Pharmaceuticals Financials at a Glance

Market Cap

$6.60K

Revenue (TTM)

$1.56M

Net Income (TTM)

-$879.00K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

29.67 (High)

Dividend

$0.00

Beta (Volatility)

29.67 (High)

Price

$0.00

Volume

376

Open

$0.00

Price

$0.00

Volume

376

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Feb 26, 2025

Dividend

$0.00

Beta (Volatility)

29.67 (High)

Price

$0.00

Volume

376

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Feb 26, 2025

ACUR News

3 Companies That Put the "Tech" in "Biotech"

Keith SpeightsMay 16, 2013

Whoa! What Just Happened to My Stock?

Rich DupreyApr 18, 2013

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Acura Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Robert B. Jones, MBA

Website

www.acurapharm.com

Headquarters

Palatine, IL 60067, US

ACUR Financials

Key Financial Metrics (TTM)

Gross Margin

94.24%

Operating Margin

-77.67%

Net Income Margin

-56.24%

Return on Equity

30.77%

Return on Capital

-321.16%

Return on Assets

-102.21%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.60K

Shares Outstanding

66.00M

Volume

376

Avg. Volume

832.339

Financials (TTM)

Gross Profit

$1.00M

Operating Income

-$1.21M

EBITDA

-$606.00K

Operating Cash Flow

-$742.00K

Capital Expenditure

$0.00

Free Cash Flow

-$742.00K

Cash & ST Invst.

$65.00K

Total Debt

$200.00K

Acura Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q4 2021YOY CHG

Revenue

$36.00K

-95.0%

Gross Profit

$9.00K

-98.7%

Gross Margin

25.00%

N/A

Market Cap

$6.60K

N/A

Market Cap/Employee

$733.33

N/A

Employees

N/A

Net Income

$29.00K

+111.9%

EBITDA

$47.00K

+142.0%

Quarterly Fundamentals

Name

Q4 2021YOY CHG

Total Cash

$65.00K

-84.3%

Total Debt

$200.00K

-96.8%

Accounts Receivable

$158.00K

-74.8%

Inventory

$0.00

N/A

Long Term Debt

$167.00K

+59.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.02%

N/A

Return on Invested Capital

-3.52%

N/A

Free Cash Flow

-$426.00K

-432.5%

Operating Cash Flow

-$426.00K

-432.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CNBXCNBX Pharmaceuticals Inc.

CNBXCNBX Pharmaceuticals Inc.$0.00-31.03%

GNLKQGeneLink, Inc.

GNLKQGeneLink, Inc.$0.00+0.00%

MRRCFWayland Group Corp.

MRRCFWayland Group Corp.$0.00+0.00%

AZFLAmazonas Florestal, Ltd

AZFLAmazonas Florestal, Ltd$0.00+0.00%

CBDXCurative Biosciences, Inc.

CBDXCurative Biosciences, Inc.$0.00+0.00%

GMVDFG Medical Innovations Holdings Ltd

GMVDFG Medical Innovations Holdings Ltd$0.00+0.00%

KALYKali, Inc.

KALYKali, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NXTCNextCure

NXTCNextCure$6.79+2.11%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.65-0.03%

BMNRBitmine Immersion Technologies

BMNRBitmine Immersion Technologies$16.07+0.10%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.36+0.01%

ERICTelefonaktiebolaget Lm Ericsson (publ)

ERICTelefonaktiebolaget Lm Ericsson (publ)$10.16-0.13%

NOKNokia

NOKNokia$11.54-0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$36.68+0.04%

Questions About ACUR

What is the current price of Acura Pharmaceuticals?

Acura Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Acura Pharmaceuticals?

Over the past 52 weeks, Acura Pharmaceuticals has traded between $0.00 and $0.01.

How much debt does Acura Pharmaceuticals have?

As of the most recent reporting period, Acura Pharmaceuticals reported total debt of $200.00K.

How much cash does Acura Pharmaceuticals have on hand?

Acura Pharmaceuticals reported $65.00K in cash and cash equivalents in its most recent financial results.

What is Acura Pharmaceuticals’s dividend yield?

Acura Pharmaceuticals does not currently have a dividend yield.

Acura Pharmaceuticals

Acura Pharmaceuticals Financials at a Glance

ACUR News

3 Companies That Put the "Tech" in "Biotech"

Whoa! What Just Happened to My Stock?

CAPScall of the Week: Acura Pharmaceuticals

3 Stocks to Get on Your Watchlist

This Week in Biotech

Why Acura Is Poised to Pull Back

Acura Investors: Why Shares Popped 70%

The Dow Catches Its Breath

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Acura Pharmaceuticals

ACUR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Acura Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACUR

What is the current price of Acura Pharmaceuticals?

What is the 52-week range for Acura Pharmaceuticals?

How much debt does Acura Pharmaceuticals have?

How much cash does Acura Pharmaceuticals have on hand?

What is Acura Pharmaceuticals’s dividend yield?

Premium Investing Services